 |
|
|
| |
LONG-ACTING IBALIZUMAB IN PATIENTS WITH MULTI-DRUG RESISTANT HIV-1: A 24-WEEK STUDY
|
| |
| |
S. LEWIS1, J. FESSEL2, B. EMU3, S. SCHRADER4, P. KUMAR5, G. RICHMOND6, S. WEINHEIMER1, C. MARSOLAIS7
1TaiMed Biologics, Irvine, CA, 2Kaiser Foundation Res. Inst., San Francisco, CA, 3Yale School of Medicine, New Haven, CT, 4Schrader Clinic, Houston, TX, 5Georgetown University, Washington, DC, 6Gary Richmond, PA, Fort Lauderdale, FL, 7Theratechnologies, Montreal, Canada
|
| |
|
|
|
|
|
